Success Stories: National Interest Waiver Won for a Senior Development Scientist in Medicinal Chemistry from Bangladesh, Thanks to Our Diligent Team of Experts
Client’s Testimonial:
“I am very happy with Chen Immigration Attorneys for my EB2-NIW. They are highly experienced and had knowledge of every parts of the process. They are very prompt at answering questions and clarifications. All my inquiries were answered and handled properly. I appreciate all their suggestions that made my case a successful one! Best of luck Chen!”
On April 19th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Development Scientist in the Field of Medicinal Chemistry (Approval Notice).
General Field: Medicinal Chemistry
Position at the Time of Case Filing: Senior Development Scientist
Country of Origin: Bangladesh
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: April 19th, 2022
Processing Time: 2 months, 9 days
Case Summary:
“[The client] is a foremost expert in the medicinal chemistry community who, throughout her career, has driven important advances in the synthesis and safety of drug molecules used for treating cancer, cardiovascular diseases, and other challenging human illnesses. Her success in doing so shows her continued research to be a boon to not only the scientific and medical communities but also healthcare systems within the U.S. and beyond.”
This is a statement taken from a letter of recommendation written by an expert in the field of medicinal chemistry for one of our clients from Bangladesh. Our client is a senior development scientist in medicinal chemistry and she wanted us to help her file an NIW (National Interest Waiver) petition.
As an expert in the field, her proposed endeavor was to continue analyzing synthetic routes to isolate, synthesize, design, and ensure the safety of novel drug molecules as a part of innovative drug discovery projects aimed toward treating cancer, heart disease, infectious disease, and more. It was thus apparent that her research is of great importance because it directly addresses cancer through drug production. According to the World Health Organization, cancer is the leading cause of death worldwide (WHO). In 2020, cancer accounted for nearly 10 million deaths globally (WHO). Thus her proposed endeavor also has broad implications for the United States, since one person dies every 36 seconds in the United States from cardiovascular disease (CDC).
So, our client’s significance in this regard was apparent. We took a look at some of her academic achievements and found that her work has also been supported by funding from the National Institutes of Health. And her research has resulted in 22 peer-reviewed journal articles (6 of them first-authored) which have been cited a total of 181 times according to Google Scholar.
Our team added additional information such as detailed descriptions of four of her key projects as evidence of her contributions to and expertise in the field of medicinal chemistry. These factors weighed in her favor and won her the approval in just 2 months and 9 days.
We are proud to have worked with her and we wish her all the best in her future endeavors.